RVNC (Revance Therapeutics) Projected Sales Volume

Revance Therapeutics Inc - graphic logo of issuer RVNC

Revance Therapeutics (RVNC) develops long-lasting neuromodulators, offering an effect that persists significantly longer than standard counterparts. The business generates revenue through the sale of fillers and injections in specialized medical centers. The company's future sales trajectory confirms the resilience of its model, where the 0.25 mark serves as a relevant indicator. However, pricing pressure on margins and integration into the holding company remain key risk factors.

Revance Therapeutics Inc - RVNC Company Projected Revenue (period 07/04/2022 - 02/16/2025)

Revance Therapeutics, Inc (RVNC) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental company analysis:Revance Therapeutics Inc
Signature product of Revance Therapeutics Inc.

The price war in the aesthetic medicine sector directly impacts the projected sales volume for Revance Therapeutics (RVNC). This indicator tracks expected revenue, separating fundamental trends from market noise. The calculation is based on the aggregation of market expectations for commercial income on a sub-daily timeframe. Such granularity allows for the verification of investment risks amid integration into a private holding. The asset is categorized as high volatility.